Trending Now
Timber Pharmaceuticals Inc. (NYSEAMERICAN: TMBR) Announce Encouraging Top-Line Results Evaluating TMB-001...
Timber Pharmaceuticals Inc. (NYSEAMERICAN: TMBR) has announced promising top-line data from the phase 2b CONTROL study evaluating TMB-001 in treating moderate to severe congenital...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Moderna Inc.’s (NASDAQ: MRNA) COVID19 Vaccine Manufacturing Partners Experiencing Delay Issues
Moderna Inc. (NASDAQ: MRNA) has announced that its manufacturing partners for CIOVID19 vaccine outside the US are experiencing delays because of lab testing challenges...
MAKE IT MODERN
LATEST REVIEWS
Are the recent gains on Longeveron Inc (NASDAQ: LGVN) sustainable ?
In recent times, Longeveron Inc. (NASDAQ: LGVN) has been at the forefront of biotechnological innovation, particularly in addressing Hypoplastic Left Heart Syndrome...
MAKE IT MODERN
PERFORMANCE TRAINING
The Commodity Stock Dip Shopping List (X, VKIN, CLF, FCX, CCJ, ADM, BHP, AA)
Inflation. War. Skyrocketing commodity prices. That’s the current context for investors looking to navigate the world right now. Crude oil has doubled...
As Crypto Heats Up, APLD and BLQC Catch Fire on Hosting Theme (MARA, SI,...
Bitcoin has been a relatively reliable leading indicator of risk appetite across global assets over the past year, leading Ark stocks and the Nasdaq...
Akcea Therapeutics Inc. (NASDAQ:AKCA) And Ionis Pharmaceuticals Inc. (NASDAQ:IONS) Announce Publication Of Neuro-TTR TEGSEDI...
Akcea Therapeutics Inc. (NASDAQ:AKCA), the majority-owned Ionis Pharmaceuticals Inc. (NASDAQ:IONS) affiliate, and Ionis Pharmaceuticals have announced the publications of its long-term data from the...
Oral PTH from Entera Bio Ltd. (NASDAQ:ENTX) Described by Clinicians as a Potential Game-Changer...
Entera Bio Ltd. (NASDAQ:ENTX) has been carrying out two studies of an orally-delivered parathyroid hormone product. The aim of the studies carried out through...
Kala Pharmaceuticals Inc. (NASDAQ:KALA) Unveils Launch Plans For EYSUVIS In Dry Eye Disease Treatment
Kala Pharmaceuticals Inc. (NASDAQ:KALA) has offered an update on its launch plans for EYSUVIS 0.25% (loteprednol etabonate ophthalmic suspension) in treating short...
MAKE IT MODERN
